Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F02B2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,090
Award facts
- Contract value 100% obligated
- $13,090.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,090.02 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic pharmaceutical used to treat moderate-to-severe eczema, asthma, and other allergic conditions, reflecting the Defense Logistics Agency's ongoing need to supply specialized medications for military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic areas to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent capability in fulfilling competitive procurements ranging from small-value transactions to substantial orders, positioning it as a key supplier within the Defense Health Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F02B2?
SPE2DR26F02B2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F02B2 worth?
The government has obligated $13,090 on SPE2DR26F02B2.
Is contract SPE2DR26F02B2 an order under another contract?
Yes. SPE2DR26F02B2 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F02B2 competed?
The extent of competition for SPE2DR26F02B2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award